Laboratory & Research News

• Marquis Who's Who Honors Matthew H. Maxwell, DBA, MS—A Leader in Clinical Research, Growth and Innovation
  (April 3, 2025) Pioneering biotechnology researcher Matthew H. Maxwell acknowledged for contributions to the life sciences industry
  
  
• Tyler L. Giess Commemorates 25 Years in Health Care
  (April 3, 2025) Tyler L. Giess serves as the director of laboratory services at Washington Regional Medical Center
  
  
• Sharon L. Telleen, PhD, Featured in the National Edition of Fortune Magazine
  (April 3, 2025) Sharon L. Telleen, PhD, shared her professional achievements and industry expertise in Fortune magazine
  
  
• Khulud Elnur Khudur, DrPH, MSLIS, MPH, BBH, CPH, Honored for Excellence in Public Health
  (April 1, 2025) Khulud Elnur Khudur, DrPH, MSLIS, MPH, BBH, CPH, is a distinguished professional with more than 10 years of professional experience
  
  
• Marquis Who's Who Honors Holly F. Lofton for Expertise in Health Care
  (April 1, 2025) Holly F. Lofton is a health care expert specializing in medical weight management and clinical research
  
  
• Jose M. Silveiras, MD, Celebrated for Accomplishments in Research and Development in the Health Care Sector
  (April 1, 2025) Jose M. Silveiras, MD, is the executive director of site relationships and clinical monitoring at Zenas BioPharma Inc.
  
  
• Creative Biolabs Advances Non-IgG Antibody Solutions for Immune System Research
  (April 1, 2025) Creative Biolabs recently announced the services for non-IgG antibody production and purification, covering the three major types: IgE, IgM, and IgA.
  
  
• Try Ace Therapeutics' Cardiac Organoid Models to Speed Up In Vitro Cardiovascular Disease Research
  (March 29, 2025) Ace Therapeutics develops tailored cardiac organoids for cardiovascular drug screening and assessment and cardiovascular regenerative medicine.
  
  
• Creative Biolabs Captures the Spotlight at Scientist Solution Vendor Event, Johns Hopkins
  (March 28, 2025) Creative Biolabs attended the Scientist Solution Vendor Event at Johns Hopkins University on March 13 as an industry exhibitor.
  
  
• Fatima Donia Mili, MD, PhD, Achieves Prominent Placement in The Wall Street Journal
  (March 27, 2025) Marquis Who's Who is proud to endorse Fatima Donia Mili, MD, PhD, in the Washington/Baltimore Edition of The Wall Street Journal
  
  
• Creative Biolabs' Comprehensive Monkeypox Vaccine Discovery Solutions to Combat the Virus
  (March 27, 2025) Creative Biolabs is a pioneer in innovation, offering cutting-edge technologies and expertise to facilitate the development of effective monkeypox vaccines.
  
  
• Fueling TIL Therapy Development: Creative Biolabs Offers Expert, End-to-End Support
  (March 26, 2025) As a reliable collaborator in immunotherapy research, Creative Biolabs offers a true one-stop TIL therapy development service from research and development commencement to preclinical research.
  
  
• Marquis Who's Who Honors David C. Aguilar, PhD, for Excellence in Pharmacology
  (March 24, 2025) David C. Aguilar, PhD, serves as the chief operating officer at SOHM Inc.
  
  
• Marquis Who's Who Honors Samuel Li, PhD, for Expertise in Life Sciences, Biotechnology and Pharmaceuticals
  (March 24, 2025) Samuel Li, PhD, is a distinguished scientist with 35 years of experience in the life sciences, biotechnology and biopharmaceutical industries
  
  
• Professor Richard Tyler Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who
  (March 24, 2025) Professor Richard Tyler has been endorsed by Marquis Who's Who as a leader in the higher education industry
  
  
• Promoting Drug and Vaccine R&D by Spike Protein Research: Creative Biolabs' Innovative Approach
  (March 21, 2025) With extensive experience in virology, Creative Biolabs, as an industry-leading CRO company, is at the forefront of SARS-CoV-2 vaccine and drug research and development.
  
  
• Creative Biolabs Accelerates Lipid-Based Drug Delivery Innovation with Enhanced Service Portfolio
  (March 21, 2025) With greater commitment to innovation, Creative Biolabs is empowering pharmaceutical companies and researchers to transcend the confines of drug delivery.
  
  
• SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
  (March 19, 2025) We will present preclinical data on targeting innate inflammation to prevent pancreatic cancer recurrence, improve complete response and survival rate in chemotherapy-treated mice, and overcome cancer resistance in those treated with immunotherapy.
  
  
• Marquis Who's Who Honors Shima T. Moein, MD, PhD, for Expertise in Medical Research and Development
  (March 18, 2025) Shima T. Moein, MD, PhD, serves as the director of research and development at Sensonics International
  
  
• Gary D. Stoner, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who
  (March 14, 2025) Gary D. Stoner, PhD, has been endorsed by Marquis Who's Who as a leader in higher education and research
  
  
• Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary
  (March 13, 2025) A milestone achievement in botanical therapeutics
  
  
• Gut Microbiota Research: Creative Biolabs Fuels Next-Gen Probiotics Development
  (March 12, 2025) Creative Biolabs is leading the way in developing next-generation probiotics by assisting in the development of engineered strains with novel methods in gut microbiota research.
  
  
• Marquis Who's Who Honors Heather Vincent, PhD, FACSM, for Expertise in Exercise Science
  (March 10, 2025) Heather Vincent is a distinguished educator, scholar and advocate
  
  
• US Kidney Research Corp Achieves Milestone in Waterless Blood Purification Technology
  (March 6, 2025) Breakthrough Brings Implantable Artificial Kidney Closer to Reality
  
  
• Marquis Who's Who Honors Mohammad Soleimani, MD, FICO, for Excellence in Ophthalmology and Medical Innovation
  (March 6, 2025) Mohammad Soleimani, MD, FICO, is a renowned ophthalmologist and innovator in artificial intelligence applications in medicine
  
  
• Marquis Who's Who Honors Deborah L. Harm, PhD, for Commitment to Neuroscience and Education
  (March 3, 2025) Deborah L. Harm is a distinguished research physiologist and registered nurse specializing in space motion sickness
  
  
• Xiaokui Zhang, PhD, Recognized for Success in Research and Development in the Biopharmaceuticals Industry
  (February 28, 2025) Xiaokui Zhang, PhD, is the chief scientific officer at Aspen Neuroscience Inc.
  
  
• Creative Biolabs Enhances Drug Delivery with Effective Liposome Solutions
  (February 25, 2025) Backed by decades of experience and technologies, Creative Biolabs is excited to announce its comprehensive portfolio of liposomal drug delivery solutions to enhance the effectiveness of drugs.
  
  
• Marquis Who's Who Honors Hengbo Zhou for Expertise in Science and Technology
  (February 21, 2025) Hengbo Zhou serves as a senior scientist of Arnatar Therapeutics
  
  
• Creative Biolabs Conjugation Technology: Antibody Targeting Carriers Driving Precision Drug Delivery
  (February 18, 2025) Creative Biolabs leads in precision drug delivery with its unique antibody-targeting carriers and innovative conjugation technology.
  
  

Press Release Distribution News Supplied By 24-7PressRelease.com